Skip to content
HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
All fellowship slots have been filled for 2019. We are currently reviewing applications for 2020.
The Pediatric Multiple Sclerosis (MS) and Related Demyelinating Diseases Fellowship at Children’s Hospital of Philadelphia provides trainees with the necessary knowledge and skills required to provide expert diagnosis and care of children with multiple sclerosis and related conditions, and to develop an appreciation of, and participation in, relevant research initiatives.
The Multiple Sclerosis (MS) and Related Demyelinating Diseases program is a tertiary, multidisciplinary clinic. Research activities focus on advanced imaging and analysis, visual sciences, and outcomes research.
Length of Fellowship: 1 year
Start Date: July 1
Location: Philadelphia, PA
Application deadline: March 1
Institutional GME Approval: Yes
ACGME Approval: No
UCNS Accreditation: No
* All slots have been filled for 2018.
The following items are required for application to the Pediatric Multiple Sclerosis and Related Demyelinating Diseases Fellowship Program:
Please submit any questions/application materials to:
Children’s Hospital of Philadelphia
Pediatric Multiple Sclerosis and Related Demyelinating Diseases Fellowship Program
Division of Neurology
Colket Translational Research Building - Room 10200-17
3501 Civic Center Boulevard
Philadelphia, PA 19104
Attn: Ashley Rees-Jones, NCERT Program Coordinator
If you have any questions at any time during the application process, please contact Ashley at 215-590-1722 or by email.
To help preserve and improve the health of our patients, their families and our employees, The Children’s Hospital of Philadelphia has a tobacco-free hiring policy. This policy applies to all candidates for employment (other than those with regularly scheduled hours in New Jersey) for all positions, including those covered by the Collective Bargaining Agreement.
Job applicants who apply after July 1, 2014, will be expected to sign an attestation stating they’ve been free of nicotine or tobacco products in any form for the prior thirty (30) days. They will also undergo a cotinine test as a part of the Occupational Health pre-placement drug screen administered after the offer of employment has been accepted but before the first day of hire.
Exemptions: Attending physicians (excluding CHOP physicians in the Care Network), psychologists, principal investigators and/or Penn-based faculty are exempt from this process to better align with our colleagues at the University of Pennsylvania Perelman School of Medicine.